[28-51-pm1] Social Pharmacy 1, Regulatory sciences

[28-51-pm1-03S] Analysis of Sample Size Allocation to Japan and Primary Endpoint in Confirmatory Multiregional Clinical Trials

○Ayumi Hasegawa¹, Shoji Sera^1,2, Naomi Nagai^1,2 (1. Lab. Reg. Sci., Fac. Pharm., Musashino Univ., 2. Res. Inst. Pharm. Sci., Musashino Univ.)

Password required to view

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.